Distruption of brain cell ion homeostasis in Alzheimer's disease by oxy radicals, and signaling pathways that protect therefrom

Chemical Research in Toxicology

Volumn 10, Issue 5, 1997, Pages 507-517

  Mattson, Mark P ^a,b   Mark, Robert J ^a   Furukawa, Katsutoshi ^a   Bruce, Annadora J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b 211 Sanders Brown Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALCIUM ION; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; BRAIN CELL; CONTROLLED STUDY; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; ION CURRENT; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; RAT; REVIEW; ANIMAL; BRAIN; CYTOLOGY; DRUG EFFECT; ION TRANSPORT; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HOMEOSTASIS; HUMANS; ION TRANSPORT; NEURONS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 0030612106     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx9601317     Document Type: Review

References (85)

1. Stadtman, E. R. (1992) Protein oxidation and aging. Science 257, 1220-1224.
2. Mattson, M. P., Cheng, B., and Smith-Swintosky, V. L. (1993) Growth factor-mediated protection from excitotoxicity and disturbances in calcium and free radical metabolism. Semin. Neurosci. 5, 295-307.
3. Bredt, D. S., and Snyder, S. H. (1992) Nitric oxide, a novel neuronal messenger. Neuron 8, 3-11.
4. Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., and Rydel, R. E. (1993) β-Amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-415.
5. Mattson, M. P. (1996) Programmed cell life: anti-apoptotic signaling and therapeutic strategies in neurodegenerative disorders. Retorative Neurol. Neurosci. 9, 191-205.
6. Benzi, G., and Moretti, A. (1995) Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biol. Med. 19, 77-101.
7. Smith, M. A., Sayre, L. M., Monnier, V. M., and Perry, G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
8. Levy, D. I., Sucher, N. J., and Lipton, S. A. (1991) Glutathione prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuropharmacol. Neurotoxicol. 2, 345-348.
9. Yang, G., Chan, P. H., Chen, J., Carlson, E., Chen, S. F., Weinstein, P., Epstein, C. J., and Kamii, H. (1994). Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25, 165-170.
10. Orr, W. C., and Sohal, R. S. (1994) Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263, 1128-1130.
11. Behl, C., Davis, J., Lesley, R., and Schubert, D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
12. Goodman, Y., Steiner, M. R., Steiner, S. M., and Mattson, M. P. (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654, 171-176.
13. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
14. Sagara, Y., Dargusch, R., Klier, F. G., Schubert, D., and Behl, C. (1996) Increased antioxidant enzyme activity in amyloid beta protein-resistant cells. J. Neurosci. 16, 497-505.
15. Watson, B. D., and Ginsberg, M. D. (1989) Ischemic injury in the brain. Role of oxygen radical-mediated processes. Ann. N. Y. Acad. Sci. 559, 269-281.
16. Lovell, M. A., Ehmann, W. D., Butler, S. M., and Markesbery, W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
17. Pappolla, M. A., Omar, R. A., Kim, K. S., and Robakis, N. K. (1992) Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am. J. Pathol. 140, 621-628.
18. Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., and Markesbery, W. R. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 88, 10540-10543.
19. Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., and Perry, G. (1994) Advanced maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. U.S.A. 91, 5710-5714.
20. Beal, M. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
21. Lafon-Cazal, M., Pietri, S., Culcasi, M., and Bockaert, J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
22. i and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
23. Estevez, A. G., Radi, R., Barbeito, L., Shin, J. T., Thompson, J. A., and Beckman, J. S. (1995) Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65, 1543-1550.
24. Connor, J. R., Menzies, S. L., St. Martin, S. M., and Mufson, E. J. (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75-83.
25. Yasui, M., Ota, K., and Garruto, R. M. (1993) Concentrations of zinc and iron in the brains of guamanian patients with amyotrophic lateral sclerosis and Parkinsonism-dementia. Neurotoxicology 14, 445-450.
26. Butterfield, D. A., Hensley, K., Harris, M., Mattson, M. P., and Carney, J. (1994) β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
27. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R., and Butterfield, D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 91, 3270-3274.
28. Lynch, G., and Seubert, P. (1989) Links between long-term potentiation and neuropathology. Ann. N. Y. Acad. Sci. 568, 171-180.
29. 2+ channels and their regulation by excitatory amino acids. Ann. N. Y. Acad. Sci. 568, 149-158.
30. Connor, J. A. (1993) Intracellular calcium mobilization by inositol 1,4,5-triphosphate: intracellular movements and compartmentalization. Cell Calcium 14, 185-200.
31. Carafoli, E., and Stauffer, T. (1994) The plasma membrane calcium pump: Functional domains, regulation of the activity, and tissue specificity of isoform expression. J. Neurobiol. 25, 312-324.
32. Mattson, M. (1992) Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27, 29-49.
33. Mattson, M. P., and Mark, R. J. (1996) Excitotoxicity and excitoprotection in vitro. Adv. Neurol. 71, 1-30.
34. Stein-Behrens, B., Mattson, M. P., Chang, I., Yeh, M., and Sapolsky, R. M. (1994) Stress excacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14, 5373-5380.
35. Bednarski, E., Vanderklish, P., Gall, C., Saido, T., Bahr, B., and Lynch, G. (1995) Translational suppression of calpain I reduces NMDA-induced spectrin proteolysis and pathophysiology in cultured hippocampal slices. Brain Res. 694, 147-157.
36. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
37. Bazan, N. G., Allan, G., and de Turco, E. B. R. (1993) Role of phospholipase A2 and membrane-derived lipid second messengers in membrane function and transcriptional activation of genes: implications in cerebral ischemia and neuronal excitability. Prog. Brain Res. 96, 247-257.
38. Mattson, M. P., Zhang, Y., and Bose, S. (1993) Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121, 1-13.
39. Yankner, B. A., and Mesulam, M. M. (1991) β-Amyloid and the pathogenesis of Alzheimer's disease. N. Engl. J. Med. 325, 1849-1857.
40. Mattson, M. P. (1990) Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4, 105-117.
41. Cheng, B., and Mattson, M. P. (1992) Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp. Neurol. 117, 114-123.
42. Busciglio, J., Lorenzo, A., Yeh, J., and Yankner, B. A. (1995) β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
43. Mattson, M. P., Rychlik, B., Chu, C., and Christakos, S. (1991) Evidence for calcium-reducing and excitoprotective roles for the calcium binding protein (calbindin-D28k) in cultured hippocampal neurons. Neuron 6, 41-51.
44. Koh, J., Yang, L. L., and Cotman, C. W. (1990) Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
45. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
46. Rohn, T. T., Hinds, T. R., and Vincenzi, F. F. (1993) Ion transport ATPases as targets for free radical damage. Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+ pump ATPase of human red blood cell membranes. Biochem. Pharmacol. 46, 525-534.
47. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
48. Miquel, J., de Juan, E., Sevila, I., Sohal, R., Ku, H., Agarwal, S., Forster, M., and Lal, H. (1994) Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74, 121-133.
49. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S. V., Sucher, N. J., Loscaizo, J., Singel, D. J., and Stamler, J. S. (1993) A redox-based mechanism for the neuroprotective and neuro-destructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632.
50. Roch, J. M., Masliah, E., Roch-Levecq, A. C., Sundsmo, M. P., Otero, D. A., Veinbergs, I., and Saitoh, T. (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc. Natl. Acad. Sci. U.S.A. 91, 7450-7454.
51. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379, 74-78.
52. Selkoe, D. J. (1993) Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16, 403-409.
53. Mattson, M. P., Furukawa, K., Bruce, A. J., Mark, R. J., and Blanc, E. M. (1996) Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. In Molecular Mechanisms of Dementia (Tanzi, R. E., and Wasco, W., Eds.) pp 103-144, Humana Press, Totowa, NJ.
54. 717) mutants. Science 264, 1336-1340.
55. Wisniewski, K. E., Wisniewski, H. M., and Wen, G. Y. (1985) Occurrence of neuropathological changes and dementia of alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278-282.
56. Busciglio, J., and Yankner, B. A. (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378, 776-779.
57. Games, D., Adams, D., Alessandrinl, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagoplan, S., Johnson-Wood, K., Khan, K., Lee, M., Lelbowitz, E., McConlogue, S., Montoya-Zavalal, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., and Zhao, J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
58. Yankner, B. A., Duffy, L. K., and Kirschner, D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
59. Pike, C., Burdick, D., Walencewicz, A., Glabe, C., and Cotman, C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1686.
60. Copani, A., Koh, J.-Y., and Cotman, C. W. (1991) β-Amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport 2, 763-765.
61. Goodman, Y., and Mattson, M. P. (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872.
62. Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., and Mattson, M. P. (1997) A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255-264.
63. 2-resistant cells lines. Do aldehyde by-products of lipid peroxidation contribute to oxidative stress? Biochem. J. 267, 453-459.
64. Kelly, J., Furukawa, K., Barger, S. W., Mark, R. J., Rengen, M. R., Roth, G., and Mattson, M. P. (1996) Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 93, 6753-6758.
65. Cheng, B., Christakos, S., and Mattson, M. P. (1994) Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
66. Mattson, M. P., Kumar, K., Cheng, B., Wang, H., and Michaelis, E. K. (1993) Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in cultured hippocampal neurons. J. Neurosci. 13, 4575-4588.
67. 2+ accumulation. Proc. Natl. Acad. Sci. U.S.A. 92, 9328-9332.
68. Bruce A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., and Mattson, M. P. (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2, 788-794.
69. Barger, S. W., Fiscus, R. R., Ruth, P., Hofmann, F., and Mattson, M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β amyloid precursor. J Neurochem. 64, 2087-2096.
70. Schubert, D., and Behl, C. (1993) The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extra-cellular matrix. Brain Res. 629, 275-282.
71. Buxbaum, J. D., Gandy, S. E., Cicchetti, P., Ehrlich, M. E., Czernik, A. J., Fracasso, R. P., Ramabhadran, R. V., Unterbeck, A. J., and Greengard, P. (1990) Processing of Alzheimer beta/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 87, 6003-6006.
72. Gabuzda, D., Busciglio, J., and Yankner, B. A. (1993) Inhibition of beta-amyloid production by activation of protein kinase C. J. Neurochem. 61, 1-4.
73. Lorenzo, A., and Yankner, B. A. (1994) β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A. 91, 12243-12247.
74. Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., and Szarek, W. A. (1995) Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat. Med. 1, 143-148.
75. Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., and Beyreuther, K. E. (1992) Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267, 18210-18217.
76. Behl, C., Widmann, M., Trapp, T., and Holsboer, F. (1995) 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
77. Goodman, Y., Bruce, A. J., Cheng, B., and Mattson, M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
78. Mark, R. J., Ashford, J. W., and Mattson, M. P. (1994) Anticonvulsants attenuate amyloid β-peptide neurotoxicity and promote maintenance of calcium homeostasis. Neurobiol. Aging 16, 187-198.
79. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372-375.
80. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res. 706, 328-332.
81. 2+ influx. J. Neurochem. 65, 1061-1068.
82. i and protects hippocampal neurons against excitotoxicity. Brain Res. 689, 141-146.
83. Olson, L., Backman, L., Ebendal, T., Eriksdotter-Jonhagen, M., Hoffer, B., Kumpel, C., Freedman, R., Giacobini, M., Meyerson, B., and Nordberg, A. (1994) Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases. J. Neurol. 242, S12-15.
84. Goodman, Y., and Mattson, M. P. (1994) Staurosporine and K-252 compounds protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury. Brain Res. 650, 170-174.
85. Nabeshima, T., Nitta, A., Fuji, K., Kameyama, T., and Hasegawa, T. (1994) Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats. Gerontology 2, 46-56.